Long-term exposure to low-concentrations of Cr(VI) induce DNA damage and disrupt the transcriptional response to benzo[a]pyrene

Toxicology

Volumn 316, Issue 1, 2014, Pages 14-24

  Ovesen, Jerald L ^a   Fan, Yunxia ^a   Chen, Jing ^a   Medvedovic, Mario ^a   Xia, Ying ^a   Puga, Alvaro ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

B a P; Chromium; Complex mixtures; Gene expression; Heavy metals; Transcriptome

Indexed keywords

BENZO[A]PYRENE; CHROMIUM; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DNA DAMAGE; FLOW CYTOMETRY; GENE EXPRESSION; HEPATOMA CELL; IMMUNOFLUORESCENCE; LONG TERM EXPOSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

B[A]P; CHROMIUM; COMPLEX MIXTURES; GENE EXPRESSION; HEAVY METALS; TRANSCRIPTOME;

ANIMALS; APOPTOSIS; BENZO(A)PYRENE; CARCINOGENS, ENVIRONMENTAL; CELL LINE, TUMOR; CHROMIUM; COLONY-FORMING UNITS ASSAY; DISEASE PROGRESSION; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; LIVER NEOPLASMS; MICE; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

EID: 84892525509     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2013.12.001     Document Type: Article

References (34)

1. Anders S., Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010, 11(10):R106.
2. Barchowsky A., O'Hara K.A. Metal-induced cell signaling and gene activation in lung diseases. Free Radic. Biol. Med. 2003, 34(9):1130-1135.
3. Birnbaum L.S., DeVito M.J. Use of toxic equivalency factors for risk assessment for dioxins and related compounds. Toxicology 1995, 105:391-401.
4. Cefalu W.T., Wang Z.Q., Zhang X.H., Baldor L.C., Russell J.C. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J. Nutr. 2002, 132(6):1107-1114.
5. Cizmas L., McDonald T.J., Phillips T.D., Gillespie A.M., Lingenfelter R.A., Kubena L.F., Phillips T.D., Donnelly K.C. Toxicity characterization of complex mixtures using biological and chemical analysis in preparation for assessment of mixture similarity. Environ. Sci. Technol. 2004, 38(19):5127-5133.
6. Collins J.F., Brown J.P., Alexeeff G.V., Salmon A.G. Potency equivalency factors for some polycyclic aromatic hydrocarbons and polycyclic aromatic hydrocarbon derivatives. Regul. Toxicol. Pharmacol. 1998, 28:45-54.
7. Conney A.H., Chang R.L., Jerina D.M., Wei S.-J.C. Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. Drug Metab. Rev. 1994, 26:125-163.
8. Dayan A.D., Paine A.J. Mechanisms of chromium toxicity, carcinogenicity and allergenicity: review of the literature from 1985 to 2000. Hum. Exp. Toxicol. 2001, 20(9):439-451.
9. Ding M., Shi X., Castranova V., Vallyathan V. Predisposing factors in occupational lung cancer: inorganic minerals and chromium. J. Environ. Pathol. Toxicol. Oncol. 2000, 19(1-2):129-138.
10. Gibb H.J., Lees P.S., Pinsky P.F., Rooney B.C. Lung cancer among workers in chromium chemical production. Am. J. Ind. Med. 2000, 38(2):115-126.
11. Ihaka P., Gentleman R. R: a language for data analysis and graphics. J. Comput. Graph. Stat. 1996, 5:299-314.
12. Kopec A.K., Kim S., Forgacs A.L., Zacharewski T.R., Proctor D.M., Harris M.A., Haws L.C., Thompson C.M. Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90 days of exposure to hexavalent chromium in drinking water. Toxicol. Appl. Pharmacol. 2012, 259(1):13-26.
13. Maier A., Dalton T.P., Puga A. Disruption of dioxin-inducible phase I and phase II gene expression patterns by cadmium, chromium, and arsenic. Mol. Carcinog. 2000, 28(4):225-235.
14. Majumder S., Ghoshal K., Summers D., Bai S., Datta J., Jacob S.T. Chromium(VI) down-regulates heavy metal-induced metallothionein gene transcription by modifying transactivation potential of the key transcription factor, metal-responsive transcription factor 1. J. Biol. Chem. 2003, 278(28):26216-26226.
15. Manning F.C., Xu J., Patierno S.R. Transcriptional inhibition by carcinogenic chromate: relationship to DNA damage. Mol. Carcinog. 1992, 6:270-279.
16. Morgan M., Anders S., Lawrence M., Aboyoun P., Pages H., Gentleman R. ShortRead: a bioconductor package for input, quality assessment and exploration of high-throughput sequence data. Bioinformatics 2009, 25(19):2607-2608.
17. Nebert D.W., Petersen D.D., Puga A. Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin. Pharmacogenetics 1991, 1:68-78.
18. O'Brien T.J., Ceryak S., Patierno S.R. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat. Res. 2003, 533(1-2):3-36.
19. Perdew G.H. Association of the Ah receptor with the 90-kDa heat shock protein. J. Biol. Chem. 1988, 263(27):13802-13805.
20. Puga A., Ma C., Marlowe J.L. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem. Pharmacol. 2009, 77(4):713-722.
21. Reyes H., Reiz-Porszasz S., Hankinson O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 1992, 256:1193-1195.
22. Saha R., Nandi R., Saha B. Sources and toxicity of hexavalent chromium. J. Coord. Chem. 2011, 64:1782-1806.
23. Schnekenburger M., Talaska G., Puga A. Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activation. Mol. Cell. Biol. 2007, 27(20):7089-7101.
24. Sexton K., Beck B.D., Bingham E., Brain J.D., DeMarini D.M., Hertzberg R.C., O'Flaherty E.J., Pounds J.G. Chemical mixtures from a public health perspective: the importance of research for informed decision making. Toxicology 1995, 105:429-441.
25. Shumilla J.A., Broderick R.J., Wang Y., Barchowsky A. Chromium(VI) inhibits the transcriptional activity of nuclear factor-kappaB by decreasing the interaction of p65 with cAMP-responsive element-binding protein-binding protein [In Process Citation]. J. Biol. Chem. 1999, 274(51):36207-36212.
26. Tanaka T., Huang X., Halicka H.D., Zhao H., Traganos F., Albino A.P., Dai W., Darzynkiewicz Z. Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents. Cytometry A 2007, 71(9):648-661.
27. Trapnell C., Pachter L., Salzberg S.L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009, 25(9):1105-1111.
28. Wei Y.D., Tepperman K., Huang M.Y., Sartor M.A., Puga A. Chromium inhibits transcription from polycyclic aromatic hydrocarbon-inducible promoters by blocking the release of histone deacetylase and preventing the binding of p300 to chromatin. J. Biol. Chem. 2004, 279(6):4110-4119.
29. Wetterhahn K.E., Hamilton J.W. Molecular basis of hexavalent chromium carcinogenicity: effect on gene expression. Sci. Total Environ. 1989, 86(1-2):113-129.
30. Wise S.S., Wise J.P. Chromium and genomic stability. Mutat. Res. 2012, 733(1-2):78-82.
31. Xu J., Manning F.C., Patierno S.R. Preferential formation and repair of chromium-induced DNA adducts and DNA-protein crosslinks in nuclear matrix DNA. Carcinogenesis 1994, 15(7):1443-1450.
32. Zhitkovich A. Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI). Chem. Res. Toxicol. 2005, 18(1):3-11.
33. Zhitkovich A. Chromium in drinking water: sources, metabolism, and cancer risks. Chem. Res. Toxicol. 2011, 24(10):1617-1629.
34. Zhitkovich A., Peterson-Roth E., Reynolds M. Killing of chromium-damaged cells by mismatch repair and its relevance to carcinogenesis. Cell Cycle 2005, 4(8):1050-1052.